Dr. Tewari on the Potential Benefits of a Mobile MRI Unit in Prostate Cancer

Video

In Partnership With:

Ashutosh K. Tewari, MD, director, Department of Urology, Mount Sinai, discusses the potential benefits of a mobile MRI unit in prostate cancer.

Ashutosh K. Tewari, MD, chairman, Milton and Carroll Petrie Department of Urology, Icahn School of Medicine, director, Department of Urology, Mount Sinai, discusses the potential benefits of a mobile MRI unit in prostate cancer.

To bridge the gap in racial disparities in prostate cancer, education, development of trust, and implementation of state-of-the-art clinical investigations and therapeutic interventions are needed, says Tewari.

In February 2021, the Milton and Carroll Petrie Department of Urology at Mount Sinai received a $3.8 million donation from Robert F. Smith to launch the Robert F. Smith Mobile MRI Unit to support African American patients with prostate cancer, explains Tewari. The mobile unit allows providers to bring MRI technology to local hospitals, clinics, and churches to streamline prostate cancer screening, detection, and management in this patient population, concludes Tewari.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD